Etiology of low vision and blindness in seven reference centers in Colombia between the years 2012 to 2017
DOI:
https://doi.org/10.15649/cuidarte.2036Keywords:
Blindness, Low Vision, Etiology, Ophthalmology, Statistics on Sequelae and DisabilityAbstract
Introduction: Low vision and blindness have high global prevalence, with categories of disability common in Colombia. Studies that characterize the etiology of permanent visual impairments are required. Objective: To identify and characterize the different causes of low vision and blindness in seven reference centers for the visually impaired population in Colombia, attended between 2012 and 2017 in six capital cities. Materials and methods: retrospective, case series, descriptive and multicenter study. Results: A sample of 879 records of visually impaired patients was available. Low vision is more prevalent for all age groups. 70% (612/879) low vision and 30% (267/879) blindness. The most common etiology in patients with low vision was age-related macular degeneration (DMAE) (24%, 144/612); in patients with blindness it was glaucoma (17%, 45/267). Discussion: Possibly in Colombia the causes of low vision and blindness go beyond cataracts, un corrected refractive errors and infectious blindness. Conclusions: The most common etiologies found are chronic and diverse eye conditions, which require specific interventions to decrease their prevalence and prevent cases of low vision and blindness.
How to cite this article: Suárez Escudero Juan Camilo, Oviedo Cáceres María del Pilar, Llano Naranjo Yuliana, Arias Uribe Johana, Villegas Mesa José Daniel, Zapata Vásquez María Camila, Ferreira Morales Jorge Luis, Reyes Cisneros Jessica Tatiana, Cano Calle Karen, Goldfeder de Gracia Sydney, González Franco Juan Felipe, Astudillo Valverde Esau. Etiología de baja visión y ceguera en siete centros de referencia en Colombia entre los años 2012 a 2017. Revista Cuidarte. 2022;13(2):e2036. http://dx.doi.org/10.15649/cuidarte.2036
References
Organización Mundial de la Salud. Informe mundial sobre la discapacidad. WHO. 2011. https://www.afro.who.int/sites/default/files/2017-06/9789240688230_spa.pdf
Organización Mundial de la Salud, Banco Mundial. Resumen: Informe mundial sobre la discapacidad. WHO. 2011. https://www.oas.org/es/sedi/ddse/paginas/documentos/discapacidad/DESTACADOS/ResumenInformeMundial.pdf
Bourne RRA, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017; 5(9): e888–e897. https://doi.org/10.1016/S2214-109X(17)30293-0
Organización Mundial de la Salud. Blindness and vision impairment. WHO. 2018. https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment
Burton MJ, Ramke J, Marques AP, Bourne RRA, Congdon N, Jones L, et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. The Lancet Global Health. 2021: 9 (4) e489-551. https://doi.org/10.1016/S2214-109X(20)30488-5
Bourne R, Steinmetz JD, Flaxman S, Briant PS, Taylor HR, Resnikoff S, et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. The Lancet Global Health. 2021; 9(2): e130–e143. https://doi.org/10.1016/S2214-109X(20)30425-3
Organización Mundial de la Salud. Vision impairment and blindness. WHO. 2018. http://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment
Fricke TR, Tahhan N, Resnikoff S, Papas E, Burnett A, Ho SM et al. Global Prevalence of Presbyopia and Vision Impairment from Uncorrected Presbyopia: Systematic Review, Meta-analysis, and Modelling. Ophthalmology. 2018; 125(10): 1492–1499. https://doi.org/10.1016/j.ophtha.2018.04.013
Leasher JL, Braithwaite T, Furtado JM, Flaxman SR, Lansingh VC, Silva JC et al. Prevalence and causes of vision loss in Latin America and the Caribbean in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2019; 103(7): 885–893. https://doi.org/10.1136/bjophthalmol-2017-311746
Leasher JL, Lansingh V, Flaxman SR, Jonas JB, Keeffe J, Naidoo Kovin, et al. Prevalence and causes of vision loss in Latin America and the Caribbean: 1990-2010. Br J Ophthalmol. 2014; 98: 619–628. http://dx.doi.org/10.1136/bjophthalmol-2013-304013
Departamento Administrativo Nacional de Estadística. Censo general 2005: Discapacidad personas con limitaciones permanentes. DANE. https://www.dane.gov.co/files/censos/discapacidad/discapacidad_mundo.pdf?phpMyAdmin=a9ticq8rv198vhk5e8cck52r11%2c3om27vamm65hhkhrtgc8rrn2g4&msclkid=12dd5fb4c4af11ec8be7d9be0a110fc4
Departamento Administrativo Nacional de Estadística. Personas con Discapacidad, retos diferenciales en el marco del COVID-19. DANE. 2020. https://www.dane.gov.co/files/investigaciones/discapacidad/2020-Boletin-personas-con-discapacidad-marco-COVID-19.pdf
Köberlein J, Beifus K, Schaffert C, Finger RP. The economic burden of visual impairment and blindness: a systematic review. BMJ Open. 2013; 3(11): e003471. http://dx.doi.org/10.1136/bmjopen-2013-003471
Wang W, Yan W, Müller A, Keel S, He M. Association of Socioeconomics With Prevalence of Visual Impairment and Blindness. JAMA Ophthalmol. 2017; 135(12): 1295–1302. http://dx.doi.org/10.1001/jamaophthalmol.2017.3449
Brody BL, Gamst AC, Williams RA, Smith AR, Lau MA PW, Dolnak DO D, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001; 108 (10): 1893–1900. http://dx.doi.org/10.1016/s0161-6420(01)00754-0
Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998; 116(4): 514–520. http://dx.doi.org/10.1001/archopht.116.4.514
Organización Mundial de la Salud. Programme for the Prevention of Blindness and Deafness.2000. Global initiative for the elimination of avoidable blindness. WHO. 2000. https://apps.who.int/iris/handle/10665/63748
Organización Mundial de la Salud. Salud ocular universal: un plan de acción mundial para 2014-2019. WHO. https://apps.who.int/iris/bitstream/handle/10665/105956/9789243506562_spa.pdf?sequence=1&isAllowed=y
Arias-Uribe J, Llano-Naranjo Y, Astudillo-Valverde E, Suárez-Escudero JC. Caracterización clínica y etiología de baja visión y ceguera en una población adulta con discapacidad visual. Rev Mex Oftalmol. 2019; 92: 201–208. https://www.medigraphic.com/pdfs/revmexoft/rmo-2018/rmo184e.pdf
Galvis Ramírez V, Rey Serrano JJ, Rodríguez Villamizar LA, Calderón C, Hernández A. Prevalencia de ceguera en el departamento de Santander - Colombia. MedUNAB. 2009; 12(2): 66–73. https://revistas.unab.edu.co/index.php/medunab/article/view/32/30
Organización Mundial de la Salud. International Statistical Classification of Diseases and Related Health Problems (ICD). WHO. 2022. http://www.who.int/classifications/icd/icdonlineversions/en/
Lavrakas P. Encyclopedia of Survey Research Methods. SAGE. 2008. http://dx.doi.org/10.4135/9781412963947
Lwanga SK, Lemeshow S. Determinación del tamaño de las muestras en los estudios sanitarios. Manual práctico. Organización Mundial de la Salud. 1991. https://apps.who.int/iris/bitstream/handle/10665/37589/9243544055_spa.pdf?sequence=1&isAllowed=y
Suárez Escudero, JC. Base datos etiologia discapacidad visual Colombia multicentrico. Mendeley Data. 2022. https://doi.org/10.17632/y4c2x2s8mj.1
Oviedo MP, Hernández ML, Ruíz M. Baja visión en Colombia: una situación invisible para el país. Rev. Fac. Nac. Salud Pública. 2015; 33(1):22-30. http://www.scielo.org.co/pdf/rfnsp/v33n1/v33n1a04.pdf
Padilla MLH, Cáceres M del PO, Rodríguez MR. Organización y gestión de la red de atención para la baja visión en Colombia. Investig. andina. 2014; 16(29); 1100–1117. http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0124-81462014000200009
Moreno Angarita M. Realidad y contexto situacional de la población con limitación visual en Colombia. una aproximación desde la justicia y el desarrollo humano. Primera edición. Bogotá D.C.: Instituto Nacional para Ciegos. 2012. https://www.coursehero.com/file/58016091/libro-idh-inci-publicadopdf/
Organización Mundial de la Salud. Ceguera y discapacidad visual. WHO. 2021. http://www.who.int/es/news-room/fact-sheets/detail/blindness-and-visual-impairment
Fedesarrollo, Fundación Saldarriaga Concha, Villar L, Martínez-Restrepo S, Gutiérrez C, Forero D. Misión Colombia Envejece: cifras, retos y recomendaciones. Editorial Fundación Saldarriaga Concha. 2015. https://www.repository.fedesarrollo.org.co/handle/11445/2724
Bourne RRA, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017; 5: e888–e897. http://dx.doi.org/10.1016/S2214-109X(17)30293-0
Rius A, Lansingh VC, Valencia LG, Carter M, Eckert K. Social inequalities in blindness and visual impairment: A review of social determinants. IJO. 2012; 60: 368-375. http://dx.doi.org/10.4103/0301-4738.100529
Clayton JA, Davis AF. Sex/Gender Disparities and Women’s Eye Health. Current Eye Research. 2015; 40 (2): 102–109. http://dx.doi.org/10.3109/02713683.2014.986333
Doyal L, Das-Bhaumik RG. Sex, gender and blindness: a new framework for equity. BMJ Open Ophthalmology. 2018; 3(1): e000135. http://dx.doi.org/10.1136/bmjophth-2017-000135
Organización Panamericana de la Salud.Cifras de Ceguera en Latinoamérica. VISIÓN 2020. https://vision2020la.wordpress.com/2014/07/14/cifras-de-ceguera-en-latinoamerica/
Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017; 5(12): e1221–e1234. http://dx.doi.org/10.1016/S2214-109X(17)30393-5
Bressler NM. Age-related macular degeneration is the leading cause of blindness. JAMA. 2004; 291(15): 1900–1901. http://dx.doi.org/10.1001/jama.291.15.1900
Spooner K, Hong T, Wijeyakumar W, Chang A. Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis. Clin Ophthalmol. 2017; 11: 161–177. http://dx.doi.org/10.2147/OPTH.S125676
Smith W, Assink J, Klein R, Mitchell P, Klaver CCW, Klein BEK, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology. 2001; 108(4): 697–704. http://dx.doi.org/10.1016/s0161-6420(00)00580-7
Chong MF, Cho HH, Jackson AJ, Bentley SA. Profile of the Australian College of Optometry low vision clinic. Clin Exp Optom. 2018; 101(6): 793–798. https://doi.org/10.1111/cxo.12805
Wong WL, Su X, Li X, Cheung MG, Klein R, Cheng C-Y, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2(2): e106-116. https://doi.org/10.1016/S2214-109X(13)70145-1
Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121(11): 2081–2090. https://doi.org/10.1016/j.ophtha.2014.05.013
Kapetanakis VV, Chan MPY, Foster PJ, Cook DG, Owen CG, Rudnicka AR. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol. 2016; 100(1): 86–93. https://doi.org/10.1136/bjophthalmol-2015-307223
Al-Merjan JI, Pandova MG, Al-Ghanim M, Al-Wayel A. Registered blindness and low vision in Kuwait. Ophthalmic Epidemiol. 2005; 12(4): 251–257. https://doi.org/10.1080/09286580591005813
Olusanya B, Onoja G, Ibraheem W, Bekibele C. Profile of patients presenting at a low vision clinic in a developing country. BMC Ophthalmol. 2012; 12: 31. https://doi.org/10.1186/1471-2415-12-31
Garweg JG. Ocular Toxoplasmosis: an Update. Klin Monbl Augenheilkd. 2016; 233: 534–539. https://doi.org/10.1055/s-0041-111821
Nussenblatt RB, Whitcup SM. Uveitis. Fundamentals and Clinical Practice: Expert Consult. 4th Edition. MOSBY Elsevier. 2010. https://issuu.com/japhsion/docs/uveitis__fundamentals_and_clinical_
Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LMG, Tan HK, Wallon M, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008; 2: e277. https://doi.org/10.1371/journal.pntd.0000277
Facio Lince LA, López de Mesa C, de-la Torre A. Toxoplasmosis ocular en Colombia: 10 años de aportes investigativos. Rev Soc Colomb Oftalmol. 2018; 51(1): 16–28. https://dialnet.unirioja.es/servlet/articulo?codigo=7025785
Hartnett ME. Advances in understanding and management of retinopathy of prematurity. Surv Ophthalmol. 2017; 62(3): 257–276. https://doi.org/10.1016/j.survophthal.2016.12.004
Todd DA, Wright A, Smith J. Severe retinopathy of prematurity in infants <30 weeks’ gestation in New South Wales and the Australian Capital Territory from 1992 to 2002. Arch Dis Child Fetal Neonatal Ed. 2007; 92(4): F251-254. https://doi.org/10.1136/adc.2006.096479
Zin A, Gole GA. Retinopathy of prematurity-incidence today. Clin Perinatol. 2013; 40(2): 185–200. https://doi.org/10.1016/j.clp.2013.02.001
Giraldo Restrepo MM, Hurtado Guzmán A, Donado Gómez JH, Molina Betancur MC. Epidemiología de la retinopatía del prematuro en Medellín, 2003-2008. Iatreia. 2011; 24(3): 250–258. http://www.scielo.org.co/pdf/iat/v24n3/v24n3a03.pdf
Zuluaga C, Sierra MV, Asprilla E. Causas de ceguera infantil en Cali, Colombia. Colombia Médica. 2005; 36(4): 235–238. http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S1657-95342005000400002#:~:text=La%20ROP%20es%20la%20principal,seguida%20por%20la%20toxoplasmosis%20ocular.
Zin A. The increasing problem of retinopathy of prematurity. Community Eye Health. 2001; 14(40): 58–59. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1705951/
Ministerio de la Protección Social Colombia. Lineamientos técnicos para la implementación de programas madre canguro en Colombia. CODAJIC. 2009, http://www.codajic.org/sites/default/files/sites/www.codajic.org/files/Lineamientos%20t%C3%A9cnicos%20para%20la%20implementaci%C3%B3n%20de%20Prgramas%20Madre%20Canguro%20.%20Colombia%202009.pdf
Ohno-Matsui K, Lai TYY, Lai C-C, Gemmy Cheung CM. Updates of pathologic myopia. Prog Retin Eye Res. 2016; 52: 156–187. https://doi.org/10.1016/j.preteyeres.2015.12.001
Cotter SA, Varma R, Ying-Lai M, Azen SP, Klein R. Causes of low vision and blindness in adult Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2006; 113(9): 1574–1582. https://doi.org/10.1016/j.ophtha.2006.05.002
Zhang X, Saaddine JB, Chou C-F, Cotch MF, Cheng Y, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010; 304(6): 649–656. https://doi.org/10.1001/jama.2010.1111
Published
How to Cite
Issue
Section
Categories
Altmetrics
Downloads
License
Journal Cuidarte, scientific publication of open access, is licensed under a Creative Commons Attribution (CC BY-NC), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Any other form of use such as reproduction, transformation, public communication or distribution, for profit, requires the prior authorization of the University of Santander UDES.
The names and e-mail addresses entered in the Journal Cuidarte will be used exclusively for the purposes stated by this magazine and will not be available for any other purpose or other person.
The articles published in the Journal Cuidarte represent the criteria of their authors and do not necessarily constitute the official opinion of the University of Santander UDES.
